A new review suggests that tirzepatide (Mounjaro, Zepbound) may have neuroprotective mechanisms that could help reduce the ...

(HealthDay)—Gastric bypass (GBP) surgery is associated with reduced symptoms and neurohormonal responses to hypoglycemia, according to a study published online June 16 in Diabetes.

Addex Scientists Discover Glucagon-like-peptide-1 (GLP-1) Induced Interaction Between GLP-1 and Gastric Inhibitory Peptide (GIP) Receptors Mon Nov 28, 2011 1:02am EST Addex Pharmaceuticals / Addex ...

Advances in drug design, such as dual and triple agonists (e.g., GLP-1/gastric inhibitory peptide (GIP) and GLP-1/GIP/glucagon receptor agonists), are expanding the therapeutic impact of these ...

The Mounjaro-like anti-obesity prescription drug Zepbound is now available at pharmacies. Health experts provide clear answers to common questions about the newest GLP-1 weight loss medication.

Overindulging in your favorite food results in obesity. Previously unknown gut-brain connection helps scientists understand why overindulging in your favorite foods causes weight gain and obesity.

"IMU-856's target, SIRT6, is highly expressed in cells of the bowel wall, including enteroendocrine cells, which produce gastrointestinal hormones such as GLP-1 and gastric inhibitory peptide (GIP).

Novo Nordisk and Septerna will jointly initiate four preclinical development programmes, targeting well-established metabolic receptors for glucagon-like peptide 1 (GLP-1), gastric inhibitory ...

Inhibitory effect of C-type natriuretic peptide on spontaneous contraction in gastric antral circular smooth muscle of rat. Acta Pharmacol Sin 2003; 24 : 1021–6. CAS PubMed Google Scholar ...